Use of Morphine Gel Topically in Patients With Stage 2-3 Wounds

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

WITHDRAWN

Clinical Phase

NA

Study Classification

INTERVENTIONAL

Study Start Date

2009-04-30

Study Completion Date

2010-04-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Morphine gel applied topically to wounds will reduce wound pain and decrease patients use of oral and intravenous pain medications, therefore reducing side effects.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Efficacy of Topical Morphine in the Treatment of Severe Local Pain of Chronic Wounds

NCT02028923

Local Pain Chronic Wounds

TERMINATED PHASE3

Morphine Gel for Bedsores

NCT00007254

Decubitus Ulcer

COMPLETED PHASE1/PHASE2

Effect of Oasis® Wound Matrix on Stage III and IV Trunk Pressure Wounds Treated With Negative Pressure Wound Therapy

NCT02246608

Open Wound Abdominal Wall Wound Non Healing

COMPLETED NA

Treatment of Chronic Wounds With Cold Plasma -Plasma Care® vs. Placebo

NCT07050667

Hard to Heal Wounds Infected Wound

COMPLETED NA

A Prospective, Open, Non-controlled Clinical Investigation to Evaluate a New Negative Pressure Wound Therapy (NPWT) System to be Used in the Treatment of Acute Non-infected Wounds and Post Surgical Infected Wounds

NCT01195896

Acute Non Infected Wounds Non Infected Post Surgical Wounds

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Patients will be randomized to receive either placebo (versa base gel) or morphine gel to wound. Patients receiving morphine gel will have a decrease in pain score and use less oral/intravenous pain medications.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Wounds

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

OTHER

Blinding Strategy

DOUBLE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Arm Title 1

None available - study is no longer active.

Group Type OTHER

None available

Intervention Type OTHER

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

None available

Intervention Type OTHER

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

STudy is no longer active

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Signed and dated consent form \& HIPAA
* \>/= 18 yo
* Single stage 2-3 wound evaluated by our wound care team
* Alert and oriented (thinking ability clear and intact, physician approval)
* English language proficiency, likely to be able to participate in all scheduled evaluations

Exclusion Criteria

* Allergy to morphine, codeine, or versa base
* pts taking medications for acute condition, other than for the wound pain (can be taking chronic pain meds if current dose stable for past 3 mo)
* Patients with neuropathies
* Patients with respiratory conditions
* Patients that are pregnant

Minimum Eligible Age

18 Years

Maximum Eligible Age

75 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No